| Merck & Co. Pays Daiichi Sankyo US$4 B Upfront for Cancer ADCs |
Abstract
pdf
HTML
|
|
Ayush Saxena |
|
| GSK Gains Rights to Janssen’s Hepatitis B Therapy JNJ-3989 for US$1 B |
Abstract
html
pdf
|
|
Lucy Haggerty |
|
| Merck KGaA Partners with Hengrui Pharma for Selective PARP1 Inhibitor and Antibody-Drug |
Abstract
html
pdf
|
|
Ashish Tripathi |
|
| Novartis Pays US$100 M Upfront for Legend Biotech’s CAR-T Cell Therapies |
Abstract
pdf
html
|
|
Lucy Haggerty |
|
| Basilea Pays US$37 M Upfront for Antifungal from Pfizer’s Amplyx |
Abstract
html
pdf
|
|
Lucy Haggerty |
|
| Merck & Co. to Acquire Caraway Therapeutics for Up to US$610 M |
Abstract
pdf
html
|
|
Lucy Haggerty |
|
